BRIEF-Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For Vtama®

Reuters
11 Apr
BRIEF-Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For Vtama®

April 11 (Reuters) - Conduit Pharmaceuticals Inc CDT.O:

  • CONDUIT PHARMACEUTICALS ANNOUNCES NOVEL COCRYSTAL PATENT FILING FOR VTAMA® (TAPINAROF) WITH ENHANCED THERAPEUTIC AND MARKET EXTENSION PROSPECTS

Source text: ID:nGNX3dZ2TK

Further company coverage: CDT.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10